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a b s t r a c t
Previous studies using transgenic Pax3cre mice have revealed roles for ﬁbroblast growth factor receptors
(Fgfrs) and Fgfr substrate 2α (Frs2α) signaling in early metanephric mesenchyme patterning and in
ureteric morphogenesis. The role of Fgfr/Frs2α signaling in nephron progenitors is unknown. Thus, we
generated mouse models using BAC transgenic Six2EGFPcre (Six2cre) mediated deletion of Fgfrs and/or
Frs2α in nephron progenitors. Six2cre mediated deletion of Fgfr1 or Fgfr2 alone led to no obvious kidney
defects. Six2creFgfr1ﬂox/ﬂoxFgfr2ﬂox/ﬂox (Fgfr1/2NP /) mice generate a discernable kidney; however, they
develop nephron progenitor depletion starting at embryonic day 12.5 (E12.5) and later demonstrate
severe cystic dysplasia. To determine the role of Frs2α signaling downstream of Fgfr2 in Fgfr1/2NP /
mice, we generated Six2cre,Fgfr1ﬂox/ﬂoxFgfr2LR/LR (Fgfr1NP /Fgfr2LR/LR) mice that have point mutations in
the Frs2α binding site of Fgfr2. Like Fgfr1/2NP / mice, Fgfr1NP /Fgfr2LR/LR develop nephron progenitor
depletion, but it does not start until E14.5 and older mice have less severe cystic dysplasia than Fgfr1/
2NP / To determine the role of Frs2α alone in nephron progenitors, we generated Six2creFrs20Aﬂox/ﬂox
(Frs2aNP /) mice. Frs2aNP /mice also develop nephron progenitor depletion and renal cysts, although
these occurred later and were less severe than in the other Six2cre mutant mice. The nephron progenitor
loss in all Six2cremutant lines was associated with decreased Cited1 expression and increased apoptosis
versus controls. FAC-sorted nephron progenitors in Six2cre Frs20Aﬂox/ﬂox mice demonstrated evidence of
increased Notch activity versus controls, which likely drives the progenitor defects. Thus, Fgfr1 and Fgfr2
have synergistic roles in maintaining nephron progenitors; furthermore, Fgfr signaling in nephron
progenitors appears to be mediated predominantly by Frs2α.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Mammalian kidney development occurs via reciprocal interac-
tions between the metanephric mesenchyme and ureteric epithe-
lium (Little and McMahon, 2012). Signaling from the metanephric
mesenchyme (MM) induces formation of the ureteric bud (UB)
from the nephric duct, which elongates and branches to ultimately
form the renal collecting ducts, pelvis, and ureter. Simultaneously,
nephron progenitors, a subpopulation of MM cells, form a cap
mesenchyme (CM) around UB tips that either self-renew or
differentiate into nephrogenic epithelia (which progress from
renal vesicles to comma-shaped bodies, S-shaped bodies and
ﬁnally immature glomeruli). The other mesenchymal lineage, the
cortical renal stroma, surrounds and interacts with nephron
progenitors and the ureteric epithelium.
Previous work has demonstrated essential roles for ﬁbroblast
growth factor receptor signaling during kidney formation
(Perantoni et al., 1995, 2005; Barasch et al., 1997; Celli et al.,
1998; Zhao et al., 2004; Grieshammer et al., 2005; Poladia et al.,
2006; Hains et al., 2008, 2010; Sims-Lucas et al., 2009a, 2011a,
2011b, 2012; Walker et al., 2013). Fgfr proteins are receptor
tyrosine kinases, which signal using intracellular adapter mole-
cules. Frs2α, a major adapter molecule constitutively bound to Fgfr
juxtamembrane domains, becomes phosphorylated upon receptor
stimulation leading to activation of Erk, Akt, and alternative forms
of protein kinase C (Ong et al., 2000; Powers et al., 2000). While
global deletion of Fgfr3 or Fgfr4 does not affect kidney morpho-
genesis in mice (Colvin et al., 1996; Weinstein et al., 1998), loss of
Fgfr1, Fgfr2, or Frs2α leads to early embryonic lethality prior to
kidney formation (Deng et al., 1994; Yamaguchi et al., 1994; Arman
et al., 1998; Xu et al., 1998; Gotoh et al., 2005).
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Our laboratory has utilized conditional knockout, receptor
isoform knockout, and receptor point mutation mouse models to
elucidate the roles of Fgfr and Frs2α signaling in the developing
kidney (Zhao et al., 2004; Poladia et al., 2006; Hains et al., 2008,
2010; Sims-Lucas et al., 2009a, 2011a, 2011b, 2012; Walker et al.,
2013). Previously, we found that Pax3cre mediated deletion of
Fgfr1 and Fgfr2 in early metanephric mesenchyme (Fgfr1/2MM /)
together resulted in severe renal dysgenesis, demonstrating the
critical and redundant roles of these receptors in establishing early
kidney mesenchyme (Poladia et al., 2006). The severity of the renal
defects in these mice precluded the ability to determine the role of
Fgfr signaling in the nephron progenitor lineage. In a separate
study, we found that mice with Pax3cre deletion of Fgfr1 and with
point mutations in the Frs2α binding site of Fgfr2 (Leucine 424 and
Arginine 426, called the “LR” allele) (Fgfr1MM /Fgfr2LR/LR) devel-
oped dilated UB tips and cystic kidneys; however, the early Six2
marked nephron progenitor population appeared normal (Sims-
Lucas et al., 2012).
Given that the Pax3cre transgenic line drives cre expression
early in both renal stromal and nephrogenic mesenchyme, we
sought to determine the speciﬁc cell autonomous requirement for
Fgfr and/or Frs2α signaling in the nephrogenic lineage (nephron
progenitors and/or their downstream derivatives). Thus, we gen-
erated a Six2-EGFPcre-driven allelic series of mice that remove Fgfr
and/or Frs2α expression in the more restricted nephron progenitor
population and at a slightly later embryonic age than the Pax3cre
mutants (Li et al., 2000; Kobayashi et al., 2008). The ﬁrst were
Six2cre Fgfr1ﬂox/ﬂoxFgfr2ﬂox/ﬂox mice, which delete Fgfr1 and Fgfr2
expression in nephron progenitors. Next, we generated Six2cre,
Fgfr1ﬂox/ﬂoxFgfr2LR/LR mice which delete Fgfr1 in nephron progeni-
tors and carry the “LR” Fgfr2 point mutation that blocks Frs2α
binding. Finally we generated Six2cre Frs20Aﬂox/ﬂox mice, which
delete Frs2α expression in nephron progenitors (but which would
allow Fgfr1 and Fgfr2 signaling through alternative adapters). We
compared these mice to one another and to the previously
described Pax3cre mutants to elucidate a novel role for Fgfr/Frs2α
signaling in the nephron progenitor population.
Materials and methods
Experimental mouse models
Transgenic Six2-EGFPcre (Six2-EGFPcre) mice (Kobayashi et al.,
2008) and/or transgenic Pax3cre mice (gift from Jon Epstein) (Li
et al., 2000), which express cre in nephron progenitors and global
metanephric mesenchyme, respectively, were bred with Fgfr1ﬂox/
ﬂox mice (gift from Janet Rossant) (Hebert et al., 2003), Fgfr2ﬂox/ﬂox
mice (gift from David Ornitz) (Ornitz and Marie, 2002), Frs2αﬂox/ﬂox
mice (gift from Fen Wang) (Lin et al., 2007), and/or Fgfr2LR/LR mice,
which have Fgfr2 point mutations converting amino acids Leu-424
(L) and Arg-426 (R) to Ala residues to prevent Frs2α association
with Fgfr2 (gift from VP Eswarakumar) (Eswarakumar et al., 2006;
Sims-Lucas et al., 2009b). The presence of a copulatory plug in the
morning was considered E0.5. Genotyping was performed by PCR,
using genomic DNA isolated from tail clippings or embryonic
tissue. All animals were housed in the vivarium at the Rangos
Research Center, at the Children's Hospital of the University of
Pittsburgh. All experiments were approved by the University of
Pittsburgh Institutional Animal Care and Use Committee.
Tissue collection, qPCR and FAC-sorting
Histological experiments were performed by ﬁxing embryos or
kidneys in 4% paraformaldehyde (PFA) at 4 1C overnight and
embedding in parafﬁn blocks. Tissue sections were then subjected
to hematoxylin and eosin (H&E) staining, immunostaining, or
in situ hybridization (ISH). Section in situ hybridization was
performed on tissue sections (8 μm) as described (Di Giovanni
et al., 2011). Digoxigenin labeled antisense and sense RNA probes
were created for Bmp7, Eya1, Lhx1, Wnt4, Osr1, Fgfr1, and Fgfr2 as
described (Di Giovanni et al., 2011).
For FAC-sorting, GFP expression was utilized to sort nephron
progenitors from E14.5 Six2-EGFPcreFrs2α ﬂox/ﬂox (Frs2aNP /) and
Six2-EGFPcreFrs2α ﬂox/þ (heterozygous control) animals. Kidneys
were collected from animals with the previously described geno-
types and were digested in a 0.3% collagenase solution (Gibco, NY)
for 10 min at 37 1C, followed by several rapid passages through a
25-gauge syringe to produce a single cell suspension. Cells were
washed several times in a 10% FBS solution. GFP-positive nephron
progenitor cells were collected in RNAeasy (Qiagen, CA) and stored
at 80 1C for RNA extraction. Approximately 50,000 cells of the
same genotype were pooled from 3–4 litters (n¼6 pools of cells
per genotype).
RNA was extracted from snap frozen E13.5 Fgfr1NP /Fgfr2LR/LR
and cre negative control kidneys (n¼3 per genotype, 4 kidneys per
group) or FAC-sorted GFP-positive E14.5 Frs2aNP / and hetero-
zygous control cells. RNA extraction was performed using the
RNAeasy Plus MicroKit (Qiagen, GmbH). Using the Beacon Designer
software program, primers for Bmp7, Brpf1, Cited1, Ctnnb1, Dpf3,
Eya1, HeyL, Jagged1, Meox1, Notch1, Osr1, Six2 and Wnt9b and the
endogenous control Gapdh were designed and manufactured (Invi-
trogen, CA). The Superscript First Strand cDNA kit (Invitrogen, CA)
and a C1000 Thermal Cycler (Biorad, CA) were used to perform the
qPCR assays.
3-Dimensional (3D) reconstruction
3D reconstructions of E13.5 control and Fgfr1NP /Fgfr2LR/LR
kidney capsules, developing nephrons, ureteric trees and ureters
were performed as described (Sims-Lucas et al., 2009a). Brieﬂy,
image layers were created from projected serial H&E stained
sections (4 μm) by tracing around capsules, nephrogenic structures
(vesicles, comma-shaped bodies, S-shaped bodies, and immature
glomeruli), and the ureteric tree (Stereoinvestigator, Microbright-
ﬁeld, MBF, and VT). Traced layers were aligned and rendered into a
3D graphical reconstruction, from which ureteric tip number and
ureteric volumes were determined.
Immunoﬂuorescence and whole mount immunoﬂuorescence
experiments
Immunoﬂuorescent microscopy was performed using 8 μm
parafﬁn sections washed in xylene and re-hydrated in ethanol.
Sections were heated in a pressure cooker in 0.1 M sodium citrate
buffer (pH 6.0), blocked in a 30% BSA/donkey serum solution, and
incubated with primary antibodies overnight at 4 1C. Tissue was
incubated with either Alexa Fluor 488/594 goat-anti-mouse or
anti-rabbit secondary antibodies (1:500, Invitrogen) and DAPI for
1 h at room temperature, mounted in VectaShield (Vector Labs,
CA), and visualized on a Leica DM2500 ﬂuorescent microscope.
The primary antibodies that were utilized were: anti-Cited1
(1:200, NeoMarkers, MI), anti-Jagged1 (1:100, Santa Cruz, TX)
anti- Notch1 (1:100, Cell Signaling, MA), anti-NCAM (1:200, Sigma,
MO), anti-Six2 (1:200, Proteintech, IL), and anti-Frs2α 1: 1:100
(Abcam, MA). DBA and LTL lectins were used at a dilution of 1:200
(Vector Labs, CA).
Apoptosis and cell proliferation assays
Terminal deoxynucleotidyl transferase dUTP nick-end labeling
(TUNEL) assays on Fgfr1/2NP / , Fgfr1NP /Fgfr2LR/LR, Frs2aNP / ,
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and control tissue sections (n¼3 per genotype) were performed
using an ApopTag Plus Fluorescein In Situ Apoptosis Detection kit
(Millipore, CA) on parafﬁn sections (8 μm) following the manu-
facturer's instructions. For the TUNEL assays, cortical kidney area
was determined by measuring the outline of the developing
nephrogenic zone on sagittal sections taken through the kidney
midline using Image J software (NIH, MD); apoptosis was quanti-
tated as a percentage of positive cells per nephrogenic zone. To
examine cell proliferation, antigen retrieval was performed as
outlined previously and tissue was incubated with anti-NCAM
(1:200, Sigma, MO) and anti-phospho histone H3 (1:200, Sigma,
MO) overnight at 4 1C. Cells that stained with both phospho-
histone H3 (proliferating) and NCAM (nephrogenic compartment)
were counted and compared in controls versus Fgfr1NP /Fgfr2LR/
LR animals (n¼3 per genotype, 2 sections per animal).
Statistical analyses
Statistical analyses of developing nephron structure number,
the rate of apoptosis and qPCR experiments were performed on
biological replicates using a Student’s t-test (Excel). All values are
represented as means7standard error with po0.05 considered
signiﬁcant.
Results
Fgfr1/2 signaling is crucial for maintenance of the nephron progenitor
population
To determine whether Fgfr signaling was required in nephron
progenitors, we used Six2creFgfr1ﬂox/ﬂoxFgfr2ﬂox/ﬂox mice to delete
Fgfr1 and/or Fgfr2 in this population. We conﬁrmed relatively
efﬁcient transgenic Six2cre driven deletion of Fgfr1 and Fgfr2 in
nephron progenitors by in situ hybridization (Fig. 1). Despite this,
we noted no defects in mice with Six2cre driven loss of Fgfr1 or Fgfr2
alone (and even with three out of four alleles deleted) (not shown).
Furthermore, unlike Pax3creFgfr1ﬂox/ﬂoxFgfr2ﬂox/ﬂox mice that formed
no discernable kidneys, (Poladia et al., 2006), E12.5 Fgfr1/2NP /
kidneys appeared relatively normal and expressed the mesenchy-
mal genes Six2, Osr1, Bmp7 and Lhx1 (Figs. 2 and S1). By E13.5,
however, Fgfr1/2NP / mutants demonstrated depletion of Six2
marked nephron progenitors (Fig. 2). Moreover, E12.5 Fgfr1/2NP /
nephron progenitors showed excessive apoptosis by ﬂuorescent
TUNEL staining versus controls (control: 33713%, mutant: 7375%,
npo0.01) (Fig. 2). In addition, E13.5 Fgfr1/2NP / nephron progeni-
tors expressed virtually no Cited1, a marker of the un-induced self-
renewing nephron progenitor sub-compartment (Boyle et al., 2008)
(Fig. 2). By E18.5, Fgfr1/2NP / mutants had small, cystic dysplastic
kidneys with an underdeveloped Six2-positive nephrogenic zone, a
reduced number of developing nephron structures, and dilated
tubules (Fig. 2). Fgfr1/2NP / mice were not viable after birth. Thus,
deletion of both Fgfr1 and Fgfr2 in nephron progenitors resulted in
loss of progenitors by apoptosis, loss of Cited1 expression, and renal
cystic dysplasia.
Loss of Fgfr–Frs2α signaling in nephron progenitors also results in
autonomous defects
To begin to interrogate the contribution of Frs2α-mediated Fgfr
signaling in nephron progenitors, we then examined Six2cre Fgfr1ﬂox/
ﬂoxFgfr2LR/LR (Fgfr1NP /Fgfr2LR/LR) mice, which delete Fgfr1 in
nephron progenitors (Fig. 1) and that have point mutations in the
Frs2α binding site on Fgfr2. Unlike Fgfr1/2NP / mice, E13.5
Fgfr1NP /Fgfr2LR/LR nephron progenitors appeared relatively normal
by Six2 immunoﬂuorescence and H&E staining (Figs. 3 and 5);
however, by E14.5 and persisting through E18.5, a substantial
number of Fgfr1NP /Fgfr2LR/LR nephron progenitors appeared to be
depleted by Six2 staining relative to controls (Fig. 3). TUNEL staining
demonstrated a dramatic increase in the number of apoptotic cells in
the cortical mesenchyme of E13.5 Fgfr1NP /Fgfr2LR/LR kidneys
versus controls (controls: 672%; Fgfr1NP /Fgfr2LR/LR: 4277%,
npo0.01) (Fig. 3), while E13.5 mutant and control nephron pro-
genitor proliferation rates appeared equivalent by phospho-histone
H3 staining (Fig. S2). Thus, the Fgfr1NP /Fgfr2LR/LR increases in
Fig. 1. Efﬁciency of Six2-EGFPcre mediated Fgfr or Frs2α deletion. (A) In E13.5 control kidneys, Fgfr1 mRNA is robustly expressed in the nephron progenitors (arrowheads)
and developing nephron structures (arrow). (B) In E13.5 Six2-EGFPcreFgfr1ﬂox/ﬂoxFgfr2LR/LR (Fgfr1NP /Fgfr2LR/LR) kidneys, nephron progenitors are devoid of Fgfr1 mRNA
(arrowhead), although rare nephron structures express Fgfr1 mRNA (arrow), likely from early nephron progenitors that escaped cre mediated deletion. (C) In E15.5 control
kidneys, Fgfr1 mRNA is also expressed strongly in nephron progenitors (arrowhead) and developing nephron structures (arrow) (D) In E15.5 Fgfr1NP /Fgfr2LR/LR kidneys, no
nephron progenitors (arrowheads) and a very few nephron structures (arrow) express Fgfr1 mRNA. (E) In E15.5 control kidneys, Fgfr2 mRNA is observed in the nephron
progenitors (arrowhead), developing nephron structures (arrow) and ureteric bud stalks (small arrow). (F) In E15.5 Six2-EGFPcreFgfr1ﬂox/ﬂoxFgfr2ﬂox/ﬂox (Fgfr1/2NP /) kidneys,
Fgfr2 expression is maintained in the ureteric bud stalks (small arrow) but absent from the nephron progenitors (arrowhead) and developing nephron structures (arrow).
(G) In an E15.5 control kidney, Frs2α immunostaining (green) is observed in nephron progenitors (arrowhead), and the ureteric epithelium (small arrow). (H) In E15.5 Six2-
EGFPcreFrs20Aﬂox/ﬂox (Frs2aNP / kidneys), Frs2α0A staining is maintained in the ureteric epithelium (small arrow), but absent from nephron progenitors (arrowhead). A–F:
scale bars¼0.25 mm. G–H: scale bar¼0.050 mm.
V. Di Giovanni et al. / Developmental Biology 400 (2015) 82–9384
apoptosis and reduction in nephron progenitors occurred slightly
later than in Fgfr1/2NP / mice.
By E18.5, Fgfr1NP /Fgfr2LR/LR embryonic kidneys displayed tubular
dilatation/cysts derived from nephron lineages including glomeruli
and proximal tubules, while ureteric bud-derived collecting ducts
appeared normal (Fig. 4). Unlike Fgfr1/2NP / mice, a small percen-
tage of Fgfr1NP /Fgfr2LR/LR pups survived after birth. In surviving
Fgfr1NP /Fgfr2LR/LR mutants, the tubular dilation was progressive and
resulted in almost complete replacement of the renal parenchyma by
cysts at post-natal day 21 (Fig. 4). Thus, while the cystic disease in
Fgfr1NP /Fgfr2LR/LR kidneys appeared to progress more slowly than in
Fgfr1/2NP / mice, ultimately, Fgfr1NP /Fgfr2LR/LR mutants ended up
with severe cystic changes.
We then compared Fgfr1NP /Fgfr2LR/LR mice with Pax3-
creFgfr1ﬂox/ﬂoxFgfr2LR/LR (Fgfr1MM /Fgfr2LR/LR) mice in which Fgfr1
is deleted throughout the entire metanephric mesenchyme. While
we previously found that E13.5 Fgfr1MM /Fgfr2LR/LR mice had
dilated and fewer ureteric tips (Sims-Lucas et al., 2012), E13.5
Fgfr1NP /Fgfr2LR/LR ureteric tips appeared normal by H&E staining
and showed no changes in average ureteric epithelium volume or
tip number by 3D reconstruction versus controls (control volume:
28.710474.03104 μm3, Fgfr1NP /Fgfr2LR/LR: 27.610472.20
104 μm3, p¼0.81) (control tips: 75718, Fgfr1NP /Fgfr2LR/LR:
46711, p¼0.16) (Fig. 4). We also found that unlike E18.5
Fgfr1NP /Fgfr2LR/LR mice that had no collecting duct dilatation
(see Fig. 4), E18.5 Fgfr1MM /Fgfr2LR/LR embryos did develop
dilated tubules from both nephron and ureteric lineages (Fig. S3).
We then assessed whether Fgfr1MM /Fgfr2LR/LR mice had
previously unrecognized nephron progenitor depletion. Indeed,
Six2 staining revealed loss in the Fgfr1MM /Fgfr2LR/LR nephron
progenitor population at E18.5 compared with controls (Fig. S4).
Thus, the Fgfr1MM /Fgfr2LR/LR and Fgfr1NP /Fgfr2LR/LR lines expose
temporal and/or spatial windows of Fgfr/Frs2α activity in kidney
mesenchyme in repressing cystogenesis in different renal lineages.
However, the Fgfr1NP /Fgfr2LR/LR and Fgfr1MM /Fgfr2LR/LR mice
also reveal that Fgfr/Frs2α signaling in the nephron progenitor
compartment is critical for nephron progenitor survival.
We then sought to determine if there were intrinsic defects in
the Fgfr1NP /Fgfr2LR/LR mutant nephron progenitor population. At
E13.5, Fgfr1NP /Fgfr2LR/LR and control kidneys had comparable
expression of the renal mesenchyme markers Eya1, Osr1, Meox1,
Brpf1 and Dpf3 (Mugford et al., 2009) (Fig. 6). In addition,
expression of Cited1 was decreased in E13.5 Fgfr1NP /Fgfr2LR/LR
kidneys by both qPCR and by immunostaining (Fig. 6), similar to
Fgfr1/2NP / kidneys. Six2mRNA levels appeared to be trending
down in E13.5 mutants versus controls. Thus, while many markers
were expressed normally in E13.5 Fgfr1NP /Fgfr2LR/LR nephron
progenitors, there was a trend for decreased Six2 mRNA expres-
sion and a marked reduction of Cited1 mRNA and protein. Thus,
Fgfr1NP /Fgfr2LR/LR nephron progenitors were depleted, similar to
what was seen in Fgfr1/2NP / kidneys, albeit with a
delayed onset.
Given that the changes in Fgfr1NP /Fgfr2LR/LR nephron pro-
genitors (increased apoptosis and loss of Cited1) started at E13.5,
we examined E13.5 Fgfr1NP /Fgfr2LR/LR mice for alterations in
factors known to regulate nephron progenitors, by tissue staining
Fig. 2. Fgfr1/2NP / mice have an early loss of nephron progenitors. (A, B) Six2 immunostaining appears similar in E12.5 control (A) and Fgfr1/2NP / (B) nephron
progenitors (arrowheads). (C, D) Six2 immunostaining remains robust in E13.5 control (C) but markedly reduced in E13.5 Fgfr1/2NP / (D) nephron progenitors (arrowheads).
(E, F) Cited1 immunostaining is present in E13.5 control nephron progenitors (E) and absent in E13.5 Fgfr1/2NP / (F) nephron progenitors (arrowheads). (G, H) TUNEL
staining at E12.5 reveals a few apoptotic cells in control cap mesenchyme (G), but signiﬁcantly more apoptotic cells in Fgfr1/2NP / (H) cap mesenchyme (arrowheads).
Kidneys are outlined by dotted line. (I, J) H&E staining at E18.5 demonstrates a well-organized nephrogenic zone (arrowhead) in the control section (I), while the
Fgfr1/2NP / mutant (J) has a sparse nephrogenic zone (arrowhead) and dilated tubules (arrow). (K, L) Six2 staining (red, arrowheads) reveals that compared to control
(K) the Fgfr1/2NP / mutant (L) has very few remaining nephron progenitors. A–H: scale bars¼0.050 mm. I–L: scale bars¼0.25 mm.
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and qPCR on whole kidney mRNA. Examination of Bmp7, a growth
factor linked to nephron progenitor survival (Blank et al., 2009), by
qPCR and in situ hybridization, revealed no signiﬁcant difference
in expression in E13.5 Fgfr1NP /Fgfr2LR/LR kidneys or nephron
progenitors compared to controls (Fig. 7). Second, immunostaining
and/or qPCR on whole kidney mRNA revealed no changes in
Fgfr1NP /Fgfr2LR/LR kidney expression of Wnt9b or canonical
Wnt readouts β-catenin and Lef1 (Fig. 7), all components of a
pathway that directs nephron progenitor cells to exit the
self-renewing stem cell niche (Karner et al., 2011). Finally, immu-
nostaining for p53, recently identiﬁed as critical for nephron
progenitor survival (Saifudeen et al., 2012), was unaltered in
Fgfr1NP /Fgfr2LR/LR kidneys (Fig. 7). Thus it appears that
Bmp7, Wnt9b, and p53 signaling (all of which are known to
be important for nephron progenitor survival) is intact in
Fgfr1NP /Fgfr2LR/LR mice.
Fig. 3. Fgfr1NP /Fgfr2LR/LR embryos progressively lose nephron progenitors and have increased apoptosis. (A, B) At E13.5, the Six2 marked nephron progenitor cap
mesenchyme population (red, arrowheads) appears similar in control (A) and Fgfr1NP /Fgfr2LR/LR kidneys (B). (C, D) At E14.5, Six2 immunostaining (red, arrowheads) in
control cap mesenchyme remains robust (C), but appears depleted in Fgfr1NP /Fgfr2LR/LR kidneys (D), revealing diminished numbers of nephron progenitors. (E, F) At E18.5,
Six2 immunostaining (red, arrowheads) reveals that compared to controls (E), Fgfr1NP /Fgfr2LR/LR kidneys demonstrate severe losses in nephron progenitors. (G, H) E13.5
TUNEL staining (green, arrowheads) reveals a few apoptotic cells in the cap mesenchyme of controls (G), but statistically more apoptotic cells (npo0.01) in the cap
mesenchyme in Fgfr1NP /Fgfr2LR/LR kidneys (H). A–B: scale bar¼0.25 mm. C–H: scale bars¼0.050 mm.
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Fig. 4. Older Fgfr1NP /Fgfr2LR/LR kidneys develop cysts derived from mesenchyme. (A–D) E18.5H&E staining shows normal renal architecture in control kidneys (A, C), but
dilated tubules (arrows) in Fgfr1NP /Fgfr2LR/LR (B, D). (E, F) E18.5 DBA lectin staining (arrows) shows normal UB/collecting duct morphology in control kidney (E) and
Fgfr1NP /Fgfr2LR/LR kidney sections (F), although the latter has non-DBA labeled dilated tubules (asterisk). (G, H) E18.5 LTL lectin staining (arrows) identiﬁes normal proximal
tubules in control kidneys (G) and dilated proximal tubules in Fgfr1NP /Fgfr2LR/LR (H). (I–L) P21 H&E staining reveals that compared to a control kidney (I, K), the
Fgfr1NP /Fgfr2LR/LR kidney (J, L) has cysts throughout the parenchyma, including in glomeruli (L, arrow). A,B, I,J: scale bar¼0.75 mm. C–H, K,L: scale bar¼0.050 mm.
Fig. 5. E13.5 Fgfr1NP /Fgfr2LR/LR kidneys have normal ureteric morphogenesis. (A, B) E13.5H&E stain of a control kidney (A) and Fgfr1NP /Fgfr2LR/LR kidney (B) shows
normal UB tips (small arrows), nephron progenitors (arrowhead) and developing nephron structures (large arrows). Scale bar¼0.25 mm. (C, D) 3D reconstructions of the
E13.5 ureteric tree appear similar between controls (C) and Fgfr1NP /Fgfr2LR/LR (D), including non-dilated ureteric tips (purple, arrows). In panels C and D: light blue
shapes¼renal vesicles, dark purple¼comma shaped bodies, red¼S-shaped bodies, green¼ immature glomeruli, and dark blue¼ureter.
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Loss of Frs2α expression in nephron progenitors also leads to
autonomous defects
To fully elucidate the importance of Frs2α-mediated Fgfr
signaling in nephron progenitors, we compared Fgfr1/2NP / and
Fgfr1NP /Fgfr2LR/LR mice to Six2creFrs2α ﬂox/ﬂox (Frs2aNP /) mice,
which lose Frs2α expression in nephron progenitors. Like the other
mutants, Frs2aNP / mice demonstrated a decrease in Six2-
labeled nephron progenitors, but not until E15.5 (Fig. 8), later
than both Fgfr1/2NP / and Fgfr1NP /Fgfr2LR/LR mice. Moreover,
Frs2aNP / nephron progenitors had a loss of Cited1 expression
(Fig. 8) and excessive nephron progenitor apoptosis versus con-
trols (control: 171%, mutant: 672%, po0.05) (Fig. 8), but again
slightly later at E14.5. By E18.5, Frs2aNP / mice displayed tubular
Fig. 6. Proﬁle of cap mesenchyme markers in E13.5 Fgfr1NP /Fgfr2LR/LR nephron progenitors: (A–D) Eya1 and Osr1 expression by in situ hybridization (arrowheads) appears
equivalent in controls (A, C) and Fgfr1NP /Fgfr2LR/LR cap mesenchyme (B, D). (E, F) Cited1 expression by immunostaining (red, arrowheads) appears normal in control
nephron progenitors (E) but virtually absent in Fgfr1NP /Fgfr2LR/LR nephron progenitors (F). (G) Graph of qPCR data showing gene expression in control (blue) and
Fgfr1NP /Fgfr2LR/LR whole kidneys (orange) reveals a possible trend for decreased Six2 mRNA expression (p¼0.06) and statistically less Cited1 mRNA (npo0.01) in the
mutants, while the expression of other mesenchymal markers appears unchanged (all other genes p40.05). A–D: scale bars¼0.050 mm. E, F: scale bar¼0.025 mm.
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dilatation/cysts and smaller kidneys than controls (Fig. 8), albeit
less severe than E18.5 Fgfr1/2NP / or Fgfr1NP /Fgfr2LR/LR mice.
While most Frs2aNP / mice survived after birth, after a week
cysts were easily detected in mutant mice and by P30, Frs2aNP /
mutant kidneys had severe cystic dysplasia, similar to P21
Fgfr1NP /Fgfr2LR/LR mice (Fig. S5).
Given that the nephron progenitor defects in Frs2aNP / mice
occurred later than in Fgfr1/2NP / and Fgfr1NP /Fgfr2LR/LR
mutants, we were able to use FAC-sorting to isolate and pool
sufﬁcient numbers of E14.5 Frs2aNP / nephron progenitors for
qPCR assessment of other candidate pathways disrupted down-
stream of the Six2cremutants. First, we conﬁrmed decreased Frs2α
and Cited1 mRNA from pooled mutant nephron progenitors versus
controls (Fig. 9). We also found equivalent Six2 and Bmp7 mRNA
levels in E14.5 Frs2aNP / pooled progenitors versus controls
(Fig. 9). We also detected marginal (12%) increases in p53 mRNA
in mutant progenitors compared with controls (as opposed to
decreases, which might be expected with nephron progenitor
loss). While Egf and Tgfα appear to support nephron progenitor
survival in vitro (Brown et al., 2011), EgfmRNAwas unchanged and
Tgfα mRNA was only marginally decreased in E14.5 Frs2aNP /
mutant cells versus controls by qPCR (Fig. S6). In contrast, Notch
signaling, a pathway known to be critical in driving nephron
differentiation (Cheng et al., 2007), appeared altered in Frs2aNP /
mutant cells. qPCR revealed signiﬁcant increases in Notch1 and
HeyL (Notch signaling readout) and a trend for increased Jagged1
(Notch ligand) in groups of pooled Frs2aNP / nephron progenitor
cells versus controls (Fig. 9). Immunostaining for Notch1 and
Jagged1 appeared to show increased protein expression in
nephron progenitors (and possibly in nephron derivatives). Thus,
Notch signaling appears increased in isolated Frs2aNP / nephron
progenitors compared to controls.
Discussion
Much of the previous work on Fgf signaling in nephron
progenitors has focused on Fgf ligands. Conditional inactivation
of Fgf8 in metanephric mesenchyme cells (stroma and nephron
progenitors) led to nephron progenitor depletion and a block in
nephron development after the renal vesicle stage (Grieshammer
et al., 2005; Perantoni et al., 2005). Our data strongly suggests that
Fgf8 is likely not the direct ligand for Fgfr1 or 2 in nephron
progenitors, given that none of our Fgfr/Frs2αmutants have a block
in nephrogenesis and that the onset of nephron progenitor
apoptosis was later in Fgf8 mutants than in Fgfr1/2NP / mice.
Also, more recent work showed that recombinant human FGF8
was unable to stimulate nephron progenitor marker expression
(including Cited1) and progenitor survival in nephrogenic zone
cultures (whereas other FGF ligands did) (Brown et al., 2011). It is
possible that Fgf8 is the ligand for Fgfr like-1 (Fgfrl1), an Fgf
receptor that has a small intracellular domain that lacks a tyrosine
kinase domain, and which when deleted largely phenocopies the
kidney phenotype of the Fgf8 conditional knockout (Gerber et al.,
2009). The fact that we did not observe a block in nephron
development suggests that while Fgf receptor-Frs2α signaling is
required for nephron progenitor renewal, it is dispensable for the
mesenchyme to epithelial transition required for later stages of
nephron formation.
Fig. 7. Bmp7, Wnt9b, and p53 appear similar in E13.5 Fgfr1NP /Fgfr2LR/LR nephron progenitors. (A, B) In situ hybridization for Bmp7 reveals similar expression levels in
control (A) and Fgfr1NP /Fgfr2LR/LR (B) nephron progenitors (arrowheads) that surround the Bmp7-positive ureteric tips (dotted lines). (C) Graph shows no change in Bmp7
mRNA expression by qPCR in controls (blue bar) versus Fgfr1NP /Fgfr2LR/LR kidneys (orange bar) (p¼0.06). (D, E) Immunostaining for β-catenin is similar in control (D) and
Fgfr1NP /Fgfr2LR/LR (E) nephron progenitors (arrowheads). (F) Graph shows no change in relative mRNA expression of Wnt9b (p¼0.52), β-catenin (p¼0.35), or Lef1 (p¼0.66)
by qPCR in Fgfr1NP /Fgfr2LR/LR (orange bars) versus control kidneys (blue bars). (G, H) Immunostaining for p53 reveals similar expression levels in control (G) and Fgfr1NP /
Fgfr2LR/LR (H) nephron progenitors (arrowheads). A, B: scale bar¼0.050 mm. D, E, G, H: scale bars¼0.25 mm.
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Among the FGF ligands that drove nephron progenitor survival
in the aforementioned nephrogenic zone cultures (FGF1, 2, 9 and
20) (Brown et al., 2011), Fgf2 is expressed by ureteric tips and was
previously shown to sustain metanephric mesenchyme survival in
rodent and Xenopus explants, alone or in combination with other
growth factors (Perantoni et al., 1995; Barasch et al., 1997, 1999;
Brennan et al., 1999; Plisov et al., 2001). Targeted deletion of Fgf2
in mice, however, results in no kidney defects (Zhou et al., 1998),
making it unlikely to be the (sole) endogenous ligand for Fgfr1 or
Fgfr2. Also, Fgf1 null mice have no apparent renal defects (alone or
in combination with Fgf2) (Miller et al., 2000). In contrast, a recent
publication revealed that global loss of Fgf9 and/or Fgf20 led to
nephron progenitor apoptosis, loss of nephron progenitor stem-
ness, and subsequent renal dysplasia that largely phenocopies our
Six2cre mutant mice (Barak et al., 2012). Thus, Fgf9 and/or Fgf20
are likely endogenous ligands for Fgfr1 and/or Fgfr2 in the
nephron progenitor compartment.
While Fgf9 and/or Fgf20 are likely the endogenous ligands for
Fgfr1 and/or Fgfr2 in nephron progenitors, there are some appar-
ent phenotypic differences between the ligand knockouts and the
Fgfr/Frs2α knockouts in this study (Barak et al., 2012). First, Barak
et al. did not describe cyst formation in their allelic series of Fgf9
and Fgf20 mutants; however, closer inspection of E16.5 and E18.5
mutant images (Figs. 1 and 2) reveal what appears to be a
glomerular cyst and dilated LTL-positive tubules (Barak et al.,
2012). Due to viability issues from lung maldevelopment, mutant
Fgf9/20 mutant mice were not aged beyond E18.5; thus it is not
possible to conﬁrm that postnatal Fgf9/20 mutant mice would
have developed marked numbers of cysts as in the postnatal Fgfr
mutants, although it would seem likely. Second, Fgf9/20 mutants
appeared to develop ectopic renal vesicles, which were not
appreciated in the Fgfr mutants (Barak et al., 2012). Indeed, 3D
reconstructions and Wnt4 section in situ hybridization in the Fgfr/
Frs2α allelic series failed to convincingly reveal ectopic renal
vesicles in the receptor/Frs2αmutants (not shown). One possibility
is that Fgf9 and/or Fgf20 are binding to and activating receptors in
the renal stromal compartment and/or the ureteric epithelium in
addition to the nephrogenic mesenchyme; thus, the loss of the
ligands could lead to defects, such as ectopic vesicles, which are
not seen in Six2cre Fgfr/Frs2α mutants.
Fig. 8. Frs2aNP / mice have a loss of nephron progenitors that is later than in Fgfr1NP /Fgfr2LR/LR and Fgfr1/2NP / mice. (A, B) Six2 immunostaining (red, arrowheads)
appears similar in E14.5 control (A) and Frs2aNP / (B) nephron progenitors. (C, D) Six2 immunostaining (red, arrowheads) remains robust in E15.5 control (C) but markedly
reduced in E15.5 Frs2aNP / nephron progenitors (D). (E, F) TUNEL staining (green, arrowheads) at E14.5 reveals few apoptotic cells in control nephron progenitors (E), but
many apoptotic cells in Frs2aNP / progenitors (F). (G, H) Cited1 immunostaining (red, arrowheads) is present in E14.5 control nephron progenitors (G) and absent in E14.5
Frs2aNP / nephron progenitors (H). (I, J) E18.5H&E section showing a normal control kidney (I) and a smaller Frs2aNP / kidney with dilated/cystic tubules (arrow). (K, L)
Six2 staining reveals that in contrast to the control (K) the Six2 marked nephron progenitors (arrowheads) are severely depleted in E18.5 Frs2aNP / mutants (L). A–D, I–L:
Scale bars¼0.25 mm. E, F: Scale bars¼0.050 mm. G, H: Scale bars¼0.020 mm.
Fig. 9. Frs2aNP / mice have increased Notch signaling in E14.5 nephron progenitors. (A) Graph of relative gene expression by qPCR in FAC-sorted E14.5 nephron progenitors
demonstrates signiﬁcantly decreased Frs2α0A and Cited10A nn0Ao0.010A, unaltered Six2 and Bmp7 (both p40.05), marginally increased p53 (npo0.05), trends for increased
Jagged1 (p¼0.1), and signiﬁcantly elevated Notch1 and HeyL (npo0.01) in Frs2aNP / (orange bars) versus controls (blue bars). (B, C) Immunostaining for NCAM (B) and
Notch 1 (C) in adjacent sections reveals limited Notch staining in nephron progenitors (arrowheads) but detectable expression in developing nephron structures (arrows) in
controls. (D, E) Immunostaining for NCAM (D) and Notch1 (E) in Frs2aNP / kidneys reveals stronger NCAM stained nephron progenitors (arrowheads) and possibly in
developing nephron structures (arrows). (F–I) Immunostaining for NCAM in controls (F) and Frs2aNP / (H) and Jagged1 in control (G) and Frs2aNP / (I) reveals increased
Jagged 1 expression in mutant nephron progenitors (arrowheads) and possibly in developing nephron structures (arrows). B–: Scale bars¼0.050 mm.
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The Fgfr1NP /Fgfr2LR/LR and Fgfr1MM /Fgfr2LR/LR lines used in
this and a previously published study (Sims-Lucas et al., 2012)
reveal temporal and/or spatial windows of Fgfr activity in the
metanephric mesenchyme lineage due to the different expression
proﬁles of the Cre lines. Fgfr1MM /Fgfr2LR/LR mice have both non-
autonomous ureteric defects (morphogenesis and tubular
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dilatation/cysts) as well as autonomous defects (loss of nephron
progenitors and tubular dilatation/cysts). In contrast, Fgfr1NP /
Fgfr2LR/LR mice have only autonomous defects (loss of nephron
progenitors and nephron-derived cysts). One possible explanation
for these differences lies in the timing of Cre expression in the two
lines. The transgenic Pax3cre line deletes in early kidney mesench-
yme (between E9.5 and 10.5) while the transgenic Six2cre line
deletes slightly later in nephron progenitors (Li et al., 2000;
Kobayashi et al., 2008). Another possible explanation is the
difference in spatial expression of the two cre lines; the Pax3cre
line drives gene deletion in both renal stromal and nephrogenic
mesenchyme, whereas the Six2cre only targets the nephrogenic
lineage. Interestingly, utilizing a Foxd1cre line (that deletes in the
renal stromal lineage) to make “FFLR” mice resulted in no apparent
ureteric or MM defects (unpublished observations). This does not
exclude the possibility that Fgfrs in the nephrogenic and stromal
lineages act cooperatively to regulate ureteric morphogenesis.
Taken together, this is the ﬁrst study revealing different temporal
and/or spatial requirements for Fgfr signaling in the developing
kidney mesenchyme.
The Fgfr1/2NP / , Fgfr1NP /Fgfr2LR/LR, and Frs2aNP / allelic
series also reveals additional insights into the relative roles of
Frs2α-dependent signaling downstream of Fgfrs in the developing
kidney. A previous study from our group showed that while both
Fgfr2 and Frs2α are critical for ureteric branching morphogenesis,
the two genes act independently in the epithelial ureteric lineage
(Sims-Lucas et al., 2011b). In contrast, our current data strongly
suggests that Frs2α is the main adapter protein for Fgfr signaling in
the mesenchymal nephron progenitor lineage. First, the three
Six2cre mutant mouse lines largely phenocopy one another.
Second, among the non-Fgfr receptor tyrosine kinases (RTKs) that
are known to utilize Frs2α0A0A i.e., Ret, neurotrophin receptors
(Trks), and anaplastic lymphoma kinase (Alk), only Alk appears to
be weakly expressed in nephron progenitors (GUDMAP Database:
http://www.gudmap.org/); furthermore, Alk / mice have no
overt kidney defects (Duyster et al., 2001). Other RTK mutants
that result in kidney defects (i.e., Ret and TrkB) are not expressed
in nephron progenitors and do not phenocopy our Six2-EGFPcre
mutants (Schuchardt et al., 1994; Garcia-Suarez et al., 2006).
While all of the Six2-EGFPcre-driven mutants displayed similar
defects (nephron progenitor loss, renal cystic hypodysplasia, etc.),
the defects started earlier or were more severe in Fgfr1/2NP /
mice compared to Fgfr1NP /Fgfr2LR/LR mice, which in turn had
more severe defects than Frs2aNP / mice. The most likely
explanation is that other Fgf receptor signaling adapters (e.g. PLCγ
or Crk2) have minor roles in transmitting Fgf receptor signaling in
nephron progenitors. Point mutations in docking sites on other
receptor tyrosine kinases (RTKs), such as platelet derived growth
factor receptor alpha, have shown additive effects of adapter
signaling (Klinghoffer et al., 2002). Taken together, while Fgfr
signaling appears to be independent of Frs2α in the ureteric
epithelium, Fgfr signaling is most likely predominantly mediated
by Frs2α in the mesenchymal nephron progenitors.
In investigating the mechanisms driving the nephron progeni-
tor defects in the Six2cre mutants, we focused on candidate
molecules/pathways known to regulate nephron progenitors.
Among these, Bmp7, Wnt9b, p53, and Egf expression appeared
to be unaltered in mutant nephron progenitors versus controls.
The statistical decreases in Tgfα expression are unlikely to have
signiﬁcant biological relevance alone, although we cannot rule out
the possibility that there is an additive effect if combined with
alterations in expression of other genes that regulate progenitor
survival. However, we detected evidence of increased Notch
signaling in mutant nephron progenitors. Previous publications
have shown that constitutive expression of either Notch1 or
Notch2 in nephron progenitors (Cheng et al., 2007; Fujimura
et al., 2010) leads to renal hypo-dysplasia, depletion of Six2
producing cells, and in the case of the Notch2 mutants, the
presence of renal cysts (Fujimura et al., 2010), similar to the
ﬁndings in our mutant mice. In other systems, Fgf signaling has
been shown to have antagonistic effects on Notch signaling (Small
et al., 2003). Thus, we hypothesize that Fgfr/Frs2α signaling
dampens Notch signaling in nephron progenitors to maintain the
proper balance between progenitor survival versus differentiation.
In summary, we have demonstrated that Fgfr/Frs2α signaling
controls the nephron progenitor population during renal develop-
ment. As the kidney forms, Fgfr signaling through the Frs2α
adapter protein regulates the number of Cited1 and Six2 expres-
sing nephron progenitor cells, and also prevents progenitor cell
apoptosis and the formation of mesenchymal cysts. This signaling
axis is not required for nephron differentiation, but is needed for
regulation of Notch signaling in the progenitor cell compartment.
These results delineate a spatial and temporal requirement for Fgfr
signaling during renal development and establish a cell autono-
mous role for signaling through Frs2α in the nephron progenitor
compartment.
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